Neutrophil counts and initial presentation of 12 cardiovascular diseases

For many years, cardiovascular diseases (CVDs) have been the number one cause of mortality in the United States. According to the Centers of Disease Control and Prevention (CDC), heart diseases have led to 614,348 deaths in 2014, which is equivalent to 192.7 deaths per 100,000 population (1). In this perspective, while healthcare providers direct their efforts at controlling the traditional cardiovascular risk factors, researchers are investigating biomarkers which could risk stratify patients and determine prognosis of CVDs.